Edition:
United States

Arcadia Biosciences Inc (RKDA.OQ)

RKDA.OQ on NASDAQ Stock Exchange Capital Market

8.16USD
18 Jun 2018
Change (% chg)

$-0.15 (-1.81%)
Prev Close
$8.31
Open
$8.20
Day's High
$8.37
Day's Low
$8.04
Volume
36,127
Avg. Vol
147,065
52-wk High
$66.42
52-wk Low
$3.60

Latest Key Developments (Source: Significant Developments)

Arcadia Biosciences Files For Mixed Shelf Of Up To $50 Mln - SEC Filing
Friday, 11 May 2018 05:56pm EDT 

May 11 (Reuters) - Arcadia Biosciences Inc ::ARCADIA BIOSCIENCES FILES FOR MIXED SHELF OF UP TO $50 MILLION - SEC FILING.  Full Article

Arcadia Biosciences Files Prospectus Related To Sale Of Up To 2.9 Mln Shares Of Common Stock By Selling Shareholders
Friday, 30 Mar 2018 04:50pm EDT 

March 30 (Reuters) - Arcadia Biosciences Inc ::ARCADIA BIOSCIENCES FILES PROSPECTUS RELATED TO SALE OF UP TO 2.9 MILLION SHARES OF COMMON STOCK BY SELLING SHAREHOLDERS - SEC FILING.  Full Article

Arcadia Biosciences Q4 Loss Per Share $1.39
Tuesday, 20 Mar 2018 04:05pm EDT 

March 20 (Reuters) - Arcadia Biosciences Inc ::ARCADIA BIOSCIENCES ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS.Q4 LOSS PER SHARE $1.39.Q4 REVENUE $1.4 MILLION VERSUS $540,000.  Full Article

Arcadia Biosciences Announces $10 Mln Private Placement
Monday, 19 Mar 2018 11:45am EDT 

March 19 (Reuters) - Arcadia Biosciences Inc ::ARCADIA BIOSCIENCES ANNOUNCES $10 MILLION PRIVATE PLACEMENT.ARCADIA BIOSCIENCES - ENTERED INTO SECURITIES PURCHASE AGREEMENTS IN CONNECTION WITH PRIVATE PLACEMENT OF $10 MILLION SHARES OF COMMON STOCK, WARRANTS.ARCADIA BIOSCIENCES INC - THE PER SHARE PURCHASE PRICE OF COMMON STOCK IS EQUAL TO $33.25, AND INITIAL EXERCISE PRICE FOR WARRANT IS EQUAL TO $45.75.  Full Article

Arcadia Biosciences announces third-quarter financial results
Thursday, 9 Nov 2017 04:05pm EST 

Nov 9 (Reuters) - Arcadia Biosciences Inc :Arcadia Biosciences announces third-quarter and nine-month 2017 financial results and business highlights.Q3 revenue fell 45 percent to $589,000.Q3 loss per share $0.11.  Full Article

Arcadia Biosciences says ‍FDA approval of Arcadia's food additive petition that Sonova GLA safflower oil is safe and nutritious for use in dog diets​
Tuesday, 15 Aug 2017 08:00am EDT 

Aug 15 (Reuters) - Arcadia Biosciences Inc :Arcadia Biosciences - ‍FDA approval of Arcadia's food additive petition that sonova gla safflower oil is safe and nutritious for use in dog diets​.Arcadia Biosciences Inc - ‍Approval allows Arcadia to launch sales of its Sonova GLA safflower oil to pet nutrition companies​.  Full Article

Arcadia Biosciences Q2 loss per share $0.09
Thursday, 10 Aug 2017 04:05pm EDT 

Aug 10 (Reuters) - Arcadia Biosciences Inc ::Arcadia Biosciences announces second-quarter and first-half 2017 financial results and business highlights.Q2 revenue rose 37 percent to $991,000.Q2 loss per share $0.09.  Full Article

Arcadia Biosciences and Dow Agrosciences to develop improved wheat quality trait​
Tuesday, 8 Aug 2017 08:00am EDT 

Aug 8 (Reuters) - Arcadia Biosciences Inc :Arcadia Biosciences - co, ‍dow Agrosciences to collaborate to jointly develop, commercialize a "improved" wheat quality trait in North America​.Arcadia Biosciences Inc - ‍under collaboration, companies will further develop and commercialize an improved wheat quality trait​.Arcadia Biosciences Inc - ‍specific financial and trait details of collaboration were not disclosed​.Arcadia Biosciences - as per deal, Dow Agrosciences will introgress Arcadia's trait into its proprietary elite germplasm lines.As per deal, Dow Agrosciences will manage all aspects related to trait commercialization​.Arcadia Biosciences - ‍certain development costs will be co-funded under collaboration agreement, commercial value will be shared by co, Dow Agrosciences​.  Full Article

Arcadia Biosciences Q1 loss per share $0.10
Wednesday, 10 May 2017 04:05pm EDT 

May 10 (Reuters) - Arcadia Biosciences Inc ::Arcadia Biosciences announces first-quarter 2017 financial results and business highlights.Q1 loss per share $0.10.Q1 revenue rose 19 percent to $1.0 million.Arcadia biosciences inc - cash on hand and liquid investments at end of Q1 totaled $48.5 million.  Full Article

Arcadia says U.S. FDA completes food additive review of co's Sonova® 400 gla safflower oil
Wednesday, 19 Apr 2017 08:00am EDT 

April 19 (Reuters) - Arcadia Biosciences Inc :u.s. Food and drug administration completes food additive review of arcadia biosciences’ sonova® 400 gla safflower oil for use in dog diets.Arcadia biosciences - fda concluded data supports safety, functionality of gla safflower oil as source of omega-6 fatty acids in dry food for adult dogs.Petition will be approved when final rule is published in federal register.  Full Article

BRIEF-Arcadia Biosciences Q1 Revenue Fell 79 Percent To $214,000

* ARCADIA BIOSCIENCES ANNOUNCES FIRST-QUARTER 2018 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS